Durability of the diagnosis of irritable bowel syndrome based on clinical criteria

Digestive Diseases and Sciences

Volumn 49, Issue 4, 2004, Pages 572-574

  Adeniji, Olaitan A ^a   Barnett, Cody B ^a   Di Palma, Jack A ^a,b  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH ALABAMA   (United States)

Author keywords

Clinical criteria; Diagnosis; Irritable bowel syndrome; Manning criteria; Rome I criteria; Rome II criteria

Indexed keywords

AGE DISTRIBUTION; CLINICAL FEATURE; COHORT ANALYSIS; COLON DIVERTICULOSIS; EVALUATION; FOLLOW UP; GALLBLADDER DISEASE; HUMAN; IRRITABLE COLON; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; UTERUS MYOMA; ADULT; AGED; ARTICLE; CLASSIFICATION; COMPARATIVE STUDY; CONSTIPATION; DIARRHEA; DISEASE COURSE; FEMALE; GASTROINTESTINAL ENDOSCOPY; HOSPITALIZATION; MALE; MIDDLE AGED; NEEDLE BIOPSY; PREDICTION AND FORECASTING; QUALITY OF LIFE; QUESTIONNAIRE; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; BIOPSY, NEEDLE; COHORT STUDIES; CONSTIPATION; DIARRHEA; DISEASE PROGRESSION; ENDOSCOPY, GASTROINTESTINAL; FEMALE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; QUALITY OF LIFE; QUESTIONNAIRES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 2942748549     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:DDAS.0000026300.47363.3b     Document Type: Review

References (27)

1. Manning AP, Thompson WG, Heaton KW, Morris AF: Towards a positive diagnosis of the irritable bowel. Br Med J 2:653-654, 1978
2. Drossman DA, Corazziari E, Talley NJ, et al.: Rome II: A multinational consensus document on functional gastrointestinal disorders. Gut 45 (Suppl II):1-81, 1999
3. Mitchell CM, Drossman DA: Survey of the AGA membership relating to patients with functional gastrointestinal disorders Gastroenterology 92:1282-1284, 1987
4. Drossman DA, Whitehead WE, Camilleri M: Irritable bowel syndrome: A technical review for practice guideline development. Gastroenterology 112:2120-2137, 1997
5. Patel RP, Petitta A, Fogel R, Peterson E, Zarowitz BJ: The economic impact of irritable bowel syndrome in a managed care setting. J Clin Gastroenterol 3:14-20, 2002
6. Camilleri M, Williams DE: Economic burden of irritable bowel syndrome: Proposed strategies to control expenditures. Pharmacoeconomics 4:331-338, 2000
7. Camilleri M: Management of the irritable bowel syndrome. Gastroenterology 120:652-668, 2001
8. Lembo T, Wright RA, Bagby B, Decker C, Gordon S, Jhingran P, Carter E, Lotronex Investigator Team: Alosetron controls bowel urgency and provides global symptom improvement in women with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol 96:2662-2670, 2001
9. Muller-Lissner SA, Fumagalli I, Bardhan KD, et al.: Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation. Alim Pharm Ther 15:1655-1666, 2001
10. Longstreth GF, Preskill DB, Youkeles L: Irritable bowel syndrome in women having diagnostic laparoscopy or hysterectomy. Relation to gynecologic features and outcome. Dig Dis Sci 35:1285-1290, 1990
11. Longstreth GF: Irritable bowel syndrome. Diagnosis in the managed care era. Dig Dis Sci 42:1105-1111, 1997
12. Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ 3rd: Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol 136:165-177, 1992
13. Talley NJ, Zinsmeister AR, Melton LJ: Irritable bowel syndrome in a community: symptom subgroups, risk factors and health care utilization. Am J Epidemiol 142:76-83, 1995
14. Kruis W, Thieme C, Weinzierl M, Schussler P, Holl J, Paulus W: A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease. Gastroenterology 87:1-7, 1984
15. Owens DM, Nelson DK, Talley NJ: The irritable bowel syndrome: Long-term prognosis and the physician-patient interaction. Ann Intern Med 122:107-112, 1995
16. Harvey RF, Mauad EC, Brown AM: Prognosis in the irritable bowel syndrome: A 5-year prospective study. Lancet 1:963-965, 1987
17. Svendsen JH, Munck LK, Andersen JR: Irritable bowel syndrome-prognosis and diagnostic safety. A 5-year follow up study. Scand J Gastroenterol 20:415-418, 1985
18. Holmes KM, Salter RH: Irritable bowel syndrome - A safe diagnosis? MBJ 285:1533-1534, 1982
19. Waller SL, Misiewicz JJ: Prognosis in the irritable bowel syndrome: A prospective study. Lancet 2:754-756, 1969
20. Chaudhary NA, Truelove SC: The irritable colon syndrome. A study of the clinical features, predisposing causes, and prognosis in 130 Cases. Q J Med 31:307-322, 1962
21. Tolliver BA, Herrera JL, DiPalma JA: Evaluation of patients who meet clinical criteria for irritable bowel syndrome. Am J Gastroenterol 89:176-178, 1994
22. Drossman DA (ed): In Rome II, the Functional Gastrointestinal Disorders, 2nd ed. Maclean, VA, Degnon Associates, 1999, pp 673-688
23. Tolliver BA, Jackson MS, Jackson KL, Barnett ED, Chastang JF, DiPalma JA: Does lactose maldigestion really play a role in the irritable bowel? J Clin Gastroenterol 23:15-17, 1996
24. Cash BD, Schoenfeld P, Chey WD: The utility of diagnostic tests in irritable bowel syndrome patients: A systematic review. Am J Gastroenterol 97:2812-2819, 2002
25. Saito YA, Locke GR, Talley NJ: A comparison of the Rome and Manning Criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol 95:2816-2824, 2000
26. Agréus L: Rome? Manning? Who cares? Am J Gastroenterol 95:2679-2681, 2000
27. Chey WD, Olden K, Carter E, Boyle J, Drossman D, Chang L: Utility of the Rome I and Rome II criteria for irritable bowel syndrome in U.S. women. Am J Gastroenterol 97:2803-2811, 2002